CELL INTELLIGENCE · 肿瘤细胞治疗研究

放射诱导的肿瘤来源细胞外囊泡联合酪氨酸激酶抑制剂：一种有效且安全的 EGFR19Del 肺腺癌治疗方法

Radiation-Induced Tumor-Derived Extracellular Vesicles Combined with Tyrosine Kinase Inhibitors: An Effective and Safe Therapeutic Approach for Lung A

自体树突状细胞治疗对糖尿病肾病（DKD）患者白蛋白尿及炎症生物标志物（白细胞介素-6、白细胞介素-10、肿瘤坏死因子α）影响的开放标签临床试验

Open-Label Clinical Trial on the Impact of Autologous Dendritic Cell Therapy on Albuminuria and Inflammatory Biomarkers (Interleukin-6, Interleukin-10

树突状细胞疫苗联合厄洛替尼治疗一例无法手术的肺腺癌患者：病例报告

Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.

标准抗癌治疗联合负载 Wilms 瘤 1 和黏蛋白 1 疫苗的树突状细胞可能对这类不可切除肺腺癌患者具有治疗作用。

胶质母细胞瘤中组织免疫成分的定量数字分析揭示了一种具有相关预后意义的免疫抑制和免疫无能反应

A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Signific

胶质瘤靶向治疗：分子方法未来的洞见

Glioma targeted therapy: insight into future of molecular approaches.

一项单臂 II 期研究，评估 DCVAC/LuCa 联合标准治疗化疗及参芪扶正注射液一线治疗晚期（IIIB/IV 期）非小细胞肺癌患者的疗效和安全性

A Single-Arm Phase II Study to Evaluate Efficacy and Safety of First-Line Treatment With DCVAC/LuCa, Standard of Care Chemotherapy and Shenqi Fuzheng

DCVAC/LuCa 联合标准治疗化疗和参芪扶正注射液在中国复发转移或晚期（IIIB/IV 期）NSCLC 患者中表现出良好获益，并显著改善气虚体质。

鉴定介导抗 HER3 CD4(+) Th1 应答的免疫原性 MHC II 类人 HER3 肽及其作为癌症疫苗的潜在用途

Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4(+) Th1 Responses and Potential Use as a Cancer Vaccine.